Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Gastric Cancer

Free Subscription 20.05.2019 3 Anticancer Res 3 BMC Cancer 1 BMC Surg 1 Cancer Lett 1 Dig Dis 1 Gastrointest Endosc 1 Int J Cancer 1 Int J Oncol 1 J Clin Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Anticancer Res

1. MURAKAMI Y, Saito H, Shimizu S, Kono Y, et al
   Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
   Anticancer Res. 2019;39:2583-2589.
   PubMed     Text format     Abstract available
   
   
2. MATSUBARA D, Konishi H, Kubota T, Kosuga T, et al
   Comparison of Clinical Outcomes of Gastrojejunal Bypass and Gastrectomy in Patients With Metastatic Gastric Cancer.
   Anticancer Res. 2019;39:2545-2551.
   PubMed     Text format     Abstract available
   
   
3. KUWADA K, Kuroda S, Kikuchi S, Yoshida R, et al
   Clinical Impact of Sarcopenia on Gastric Cancer.
   Anticancer Res. 2019;39:2241-2249.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

4. WANG F, He MM, Wang ZX, Li S, et al
   Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.
   BMC Cancer. 2019;19:460.
   PubMed     Text format     Abstract available
   
   
5. LI Q, Xu X, Su D, Zhou T, et al
   Long-term survival of an elderly patient with advanced gastric cancer after combination therapy: a case report and literature review.
   BMC Cancer. 2019;19:459.
   PubMed     Text format     Abstract available
   
   
6. MARTINEZ-CAMPOS C, Torres-Poveda K, Camorlinga-Ponce M, Flores-Luna L, et al
   Polymorphisms in IL-10 and TGF-beta gene promoter are associated with lower risk to gastric cancer in a Mexican population.
   BMC Cancer. 2019;19:453.
   PubMed     Text format     Abstract available
   
   

   
   BMC Surg

7. TAN Z, Xie P, Qian H, Yao X, et al
   Clinical analysis of prophylactic cholecystectomy during gastrectomy for gastric cancer patients: a retrospective study of 1753 patients.
   BMC Surg. 2019;19:48.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Lett

8. YUAN J, Yin Z, Tan L, Zhu W, et al
   Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer.
   Cancer Lett. 2019 May 9. pii: S0304-3835(19)30282.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis

9. ESAKI M, Hatta W, Shimosegawa T, Oyama T, et al
   Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric Cancer.
   Dig Dis. 2019 May 16:1-11. doi: 10.1159/000499538.
   PubMed     Text format     Abstract available
   
   

   
   Gastrointest Endosc

10. TATE DJ, Klein A, Sidhu M, Desomer L, et al
    Endoscopic submucosal dissection for suspected early gastric cancer: absolute versus expanded criteria in a large Western cohort (with video).
    Gastrointest Endosc. 2019 May 8. pii: S0016-5107(19)31669.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

11. BOBROVNITCHAIA I, Valieris R, Drummond Couto Duarte R, Lima JP, et al
    APOBEC-mediated DNA alterations: a possible new mechanism of carcinogenesis in EBV-positive gastric cancer.
    Int J Cancer. 2019 May 15. doi: 10.1002/ijc.32411.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

12. GAN L, Lv L, Liao S
    Long noncoding RNA H19 regulates cell growth and metastasis via the miR223p/Snail1 axis in gastric cancer.
    Int J Oncol. 2019;54:2157-2168.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

13. BONNOT PE, Piessen G, Kepenekian V, Decullier E, et al
    Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.
    J Clin Oncol. 2019 May 14:JCO1801688. doi: 10.1200/JCO.18.01688.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

14. QIU HB, Zhang LY, Ren C, Zeng ZL, et al
    Correction: Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/beta-Catenin Signaling.
    PLoS One. 2019;14:e0217124.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: